US$ 21.33
glp-1 or metformin Are GLP-1s and SGLT2s replacements for in addition to Metformin? Comparing Glucagon‐like peptide‐1 receptor agonists
Description
References Bozkurt, B

A longitudinal study of post-approval clinical trials found that the number of newly initiated trials for small-molecule drugs dropped by 45.3% following the IRAs passage, as companies redirected capital toward biologics that offer a longer window of pricing freedom

An in-house only answer is a switch-providers signal
Yet putting patients into a hyperthyroid state has consequences--often producing dangerous increases in heart rate, body temperature and blood pressure

doi: 10.1177/1533317513494457
These social determinants of health create additional complexity in treatment implementation, particularly in underserved populations where obesity prevalence is often highest
